🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareInsurance denied my prior auth — successful appeal letter template

Insurance denied my prior auth — successful appeal letter template

InsuranceTom Mon, Apr 20, 2026 at 11:11 AM 9 replies 565 viewsPage 1 of 2
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Apr 20, 2026 at 11:11 AM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about cost and coverage, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

The condition it depends on

Coverage criteria are plan-specific rather than insurer-specific. Two people with the same insurer and different employers have different rules, which is why "my insurer covers it" is not transferable information.

What I am not sure about

What would genuinely help is knowing what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. I would rather have one careful answer than five confident ones.

— InsuranceTom · corrections welcome and will be edited into this post with credit
19 14lisa_labSD, adam_van, Dr.SurgeonPGH and 16 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Apr 20, 2026 at 11:23 AM#2
InsuranceTom said:
Denials are usually procedural rather than clinical, and the order that works reflects that.
InsuranceTom said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

18 13dave_SLC, FDA_TrackerJim, ricardo_MIA and 15 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Apr 20, 2026 at 11:35 AM#3
InsuranceTom said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

17 12PharmHunterJen, TomTeleRx, DoseLogDan and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Apr 20, 2026 at 11:47 AM#4
Dr.SurgeonPGH said:
The affordability discussion here usually stops at individual tactics.

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $250/month (eating less)
  • Restaurants: SAVED $220/month (fewer meals out)
  • Alcohol: SAVED $170/month (stopped drinking)
  • Life insurance: Premium REDUCED by $40/month (lower BMI)
  • Copays: SAVED $70/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

16 11LabKate, kate.chem, DataDave and 13 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Apr 20, 2026 at 12:51 PM#5
PeptideChemSF said:
InsuranceTom said: ...my insurance denied cost and coverage coverage because...

Same experience, arrived at from the opposite direction. Nothing to add that would improve it.

15 10RunnerRach, TrialNerd_Beth, HPLC_Greg and 12 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register